Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: A randomized trial from the Lymphoma Group of Central Sweden

The Cancer and Leukemia Group B Lymphoma Committee

“…However, this finding has not been consistently observed in other studies. Nevertheless, the prolonged follow-up reported in this study clearly showed that more intensive treatment did not necessarily confer meaningful clinical benefit in these diseases, similar to other reports (15,16).…”

Prolonged disease‐free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma

“…Both alkylating agents and purine analogs are highly active in FL [9,10], which make them attractive agents for a combination chemotherapy regimen.…”

Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma

“…Although a wide variety of chemotherapeutic options are available for patients with B-cell NHL, these drugs, even when combined with radiation therapy, have not resulted in long-term disease-free survival in the majority of the patients. 1,2 Over the last decade, rituximab treatment has revolutionized the therapy of NHL. However, as these patients progress after receiving multiple rituximab-based regimens, alternative treatment options are needed for this group of patients as well.…”